Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 11/20 | 0.52 |
| ▸ | ITGA2B | P08514 | 11/20 | 0.52 |
| ▸ | ACACB | O00763 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 3/20 | 0.44 |
| ▸ | ACACA | Q13085 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14547360 | 0.77 | ITGB3 (0.48) | ITGB3ITGA2BALDH1A1LMNAPPARG | |
| SCHEMBL24899918 | 0.77 | ITGB3 (0.48) | ITGB3ITGA2BPPARG | |
| SCHEMBL15214440 | 0.77 | GLA (0.46) | ITGB3ITGA2BMEN1ALDH1A1LMNA | |
| SCHEMBL22472727 | 0.76 | ITGB3 (0.50) | ITGB3ITGA2BPPARG | |
| SCHEMBL17985761 | 0.76 | CPA1 (0.42) | ITGB3ITGA2BACACBPPARG | |
| SCHEMBL31688995 | 0.74 | ITGB3 (0.63) | ITGB3ITGA2BPPARG | |
| SCHEMBL3051539 | 0.74 | PTPN1 (0.52) | — | |
| SCHEMBL2619544 | 0.73 | PPARG (0.44) | ITGB3ITGA2BMEN1ALDH1A1LMNA | |
| SCHEMBL23695619 | 0.72 | ITGB3 (0.58) | ITGB3ITGA2BACACBALDH1A1PPARG | |
| SCHEMBL18262496 | 0.71 | LDHA (0.57) | KMT2APPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3812376-A1 | PACLITAXEL-LIPID-POLYSACCHARIDE DUAL-TYPE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | Santolecan Pharmaceuticals LLC (US) | 2021-04-28 | — | — | EP | disclosed |